Cytomx analysts

WebApr 6, 2024 · CytomX Therapeutics is a smaller company with a market capitalization of US$181m, so it may still be flying under the radar of many institutional investors. In the chart below, we can see that... WebWhat are analysts forecasts for CytomX stock? The 16 analysts offering price forecasts for CytomX have a median target of 6.42, with a high estimate of 16.00 and a low estimate …

IPO Preview: CytomX Therapeutics (NASDAQ:CTMX) Seeking Alpha

WebApr 5, 2024 · CytomX Therapeutics - CTMX News Today $1.80 -0.04 (-2.17%) (As of 03/21/2024 12:00 AM ET) Compare Today's Range $1.77 $1.87 50-Day Range $1.84 $2.86 52-Week Range $1.17 $3.12 Volume 946,693 shs Average Volume 2.86 million shs Market Capitalization $118.94 million P/E Ratio N/A Dividend Yield N/A Price Target $3.46 … WebAnalyst jobs 760,055 open jobs Coordinator jobs 540,291 open jobs Help Desk Technician jobs 5,545 open jobs Administrator jobs 476,673 open jobs ... cannot get through to scottish power https://plurfilms.com

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives Average …

WebApr 6, 2024 · According to analysts, CytomX Therapeutics's stock has a predicted upside of 87.89% based on their 12-month price targets. What analysts cover CytomX … WebAnalyst Coverage. CytomX Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding CytomX Therapeutics, … Annual Reports - Analyst Coverage CytomX Therapeutics, Inc. PD-1 Probody™ Therapeutic Anti-tumor Efficacy and Protection Against … CytomX Therapeutics, Inc. 151 Oyster Point Blvd Suite 400 South San Francisco, CA … Mr. Ogden joined CytomX in August of 2024 after a 16-year tenure at Eli Lilly and … SOUTH SAN FRANCISCO, Calif. , March 22, 2024 (GLOBE NEWSWIRE) -- … Stock Information - Analyst Coverage CytomX Therapeutics, Inc. Events and Presentations - Analyst Coverage CytomX Therapeutics, Inc. WebApr 14, 2024 · CytomX Therapeutics, Inc. (NASDAQ:CTMX– Get Rating) has received an average rating of “Hold” from the twelve analysts that are covering the firm, Marketbeatreports. One equities research... f key code

CytomX Therapeutics, Inc. (CTMX) Latest Stock Analysis

Category:CTMX CytomX Therapeutics, Inc. - SeekingAlpha

Tags:Cytomx analysts

Cytomx analysts

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives Average …

WebBuild your future. DXC is where brilliant people embrace change and seize opportunities to advance their careers and amplify customer success. 240+. customers in the. Fortune … WebJul 7, 2024 · Analysts have provided the following ratings for CytomX Therapeutics (NASDAQ:CTMX) within the last quarter: These 8 analysts have an average price target …

Cytomx analysts

Did you know?

WebApr 14, 2024 · CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Rating) has received an average rating of “Hold” from the twelve analysts that are covering the firm, Marketbeat … WebThe CytomX Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, …

WebMar 30, 2024 · CytomX Therapeutics Stock Performance NASDAQ:CTMX opened at $1.54 on Thursday. The firm's fifty day simple moving average is $2.25 and its 200 day simple moving average is $1.84. CytomX Therapeutics has a twelve month low of $1.17 and a twelve month high of $3.02. Institutional Investors Weigh In On CytomX Therapeutics WebCytomX Therapeutics Stock (NASDAQ:CTMX), Analyst Ratings, Price Targets, Predictions. Analysts publish ratings and price targets on most stocks. Benzinga tracks …

WebBased on analysts offering 12 month price targets for CTMX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . WebThe latest price target for . CytomX Therapeutics (NASDAQ: CTMX) was reported by Mizuho on March 28, 2024.The analyst firm set a price target for $2.00 expecting CTMX to rise to within 12 months ...

WebDXC Technology (NYSE: DXC) helps global companies run their mission critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security …

WebOct 8, 2015 · Based in South San Francisco, CA, CytomX Therapeutics (NASDAQ: CTMX) scheduled a $97 million IPO on Nasdaq with a market capitalization of $524 million at a price range midpoint of $15 for ... can not getting enough protein make you tiredWebMar 20, 2024 · CytomX Therapeutics Price Performance. Shares of NASDAQ:CTMX opened at $1.86 on Monday. The company has a market capitalization of $122.91 million, a price-to-earnings ratio of -1.25 and a beta of ... cannot get through to irs to verify identityWebApr 10, 2024 · CytomX Therapeutics presently has a consensus target price of $3.17, indicating a potential upside of 103.30%. Stoke Therapeutics has a consensus target price of $24.57, indicating a potential ... f key capWebApr 14, 2024 · CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Rating) has received an average rating of "Hold" from the twelve analysts that are covering the firm, Marketbeat reports.One equities research analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and two have assigned a buy recommendation to the … f key for full screen windows 10WebApr 14, 2024 · CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives Average Rating of “Hold” from Analysts Globe Life (NYSE:GL) PT Lowered to $129.00 Morgan Stanley Lowers ICL Group (NYSE:ICL) Price Target to $7.50 f key brightness shortcutWebApr 13, 2024 · This is a summary of recent ratings and recommmendations for CytomX Therapeutics and Stoke Therapeutics, as provided by MarketBeat. CytomX Therapeutics currently has a consensus price target of $3.17, indicating a potential upside of 94.57%. Stoke Therapeutics has a consensus price target of $24.57, indicating a potential upside … f key for print screenWebApr 14, 2024 · CytomX Therapeutics, Inc. ( NASDAQ:CTMX – Get Rating) has been assigned a consensus recommendation of “Hold” from the twelve analysts that are … f key for number lock